Researcher
Sigrid Stroobants
- Keywords:Medicine
- Disciplines:Cancer diagnosis, Biomarker evaluation, Nuclear imaging, Neurosciences not elsewhere classified
Affiliations
- Molecular Imaging and Radiology (MIRA) (Research group)
Responsible
From1 Jan 2019 → Today - Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO) (Research group)
Member
From1 Sep 2008 → 31 Dec 2018
Infrastructure
1 - 1 of 1
- Flanders BioImaging (FBI/EBI) (Consortium partner)
Projects
11 - 20 of 29
- Multidimensional analysis of the nervous system in health and disease (µNeuro).From1 Jan 2020 → TodayFunding: BOF - research organisations, Fund Recuperation Fiscal Exemption
- Development of new TCO-probes and their evaluation for a novel pre-targeted intracellular PET imaging strategy.From1 Nov 2019 → 31 Oct 2023Funding: FWO fellowships
- Prediction of tumor response to treatment: clinical translation of (99mTc)-Duramycin.From1 Feb 2019 → 31 Jan 2024Funding: Foreign public sponsor
- Development of novel cell death PET imaging probes for early treatment response assessment.From1 Oct 2018 → 30 Sep 2022Funding: BOF - Doctoral projects
- Preclinical characterization and biopharmaceutical optimization of the autophagy inhibitor UAMC-2526 for oncotherapy.From1 Jan 2018 → 31 Dec 2020Funding: IOF - Industrial Research Fund
- Development of novel cell death PET imaging probes for early treatment response evaluationFrom1 Oct 2017 → 30 Sep 2020Funding: FWO fellowships
- Imaging methodology for Huntington's disease.From1 Jul 2016 → 30 Jun 2017Funding: Fund Recuperation Fiscal Exemption
- Evaluation of the role of phosphodiesterase 7 and 10 in obsessivecompulsive disorders by positron emission tomography.From1 Oct 2015 → 15 Feb 2016Funding: FWO fellowships
- Poxylation as next generation Pegylation.From1 Feb 2013 → 31 Jan 2014Funding: SBO (Strategic basic research)
- PET and SPECT imaging of protease activity by activitybased probes.From1 Jan 2013 → 31 Dec 2016Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 155
- Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial)(2024)
Authors: Magdalena Mileva, Elisabeth G.E. de Vries, Thomas Guiot, Zena Wimana, Anne-Leen Deleu, Carolien P. Schroder, Yolene Lefebvre, Marianne Paesmans, Sigrid Stroobants, Manon Huizing, et al.
Pages: 1 - 10 - Design, synthesis, and evaluation of Trans-cyclooctene (TCO) and cis-dioxolane fused TCO (d-TCO) probes for bioorthogonal pretargeted PET imaging(2024)
Authors: Karuna Adhikari, Koen Augustyns, Filipe Elvas, Sigrid Stroobants
Number of pages: 244 - Prospective comparison of [¹⁸F]AlF-NOTA-octreotide PET/MRI to [⁶⁸Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients(2023)
Authors: Lennert Boeckxstaens, Elin Pauwels, Vincent Vandecaveye, Wies Deckers, Frederik Cleeren, Jeroen Dekervel, Timon Vandamme, Kim Serdons, Michel Koole, Guy Bormans, et al.
Pages: 1 - 13 - ¹⁸F-AlF-NOTA-octreotide outperforms ⁶⁸Ga-DOTA-TATE/-NOC PET in neuroendocrine tumor patients(2023)
Authors: Elin Pauwels, Frederik Cleeren, Térence Tshibangu, Michel Koole, Kim Serdons, Lennert Boeckxstaens, Jeroen Dekervel, Timon Vandamme, Willem Lybaert, Bliede Van den Broeck, et al.
Pages: 632 - 638 - Characterization of structurally diverse ¹⁸F-labeled d-TCO derivatives as a PET probe for bioorthogonal pretargeted imaging(2023)
Authors: Karuna Adhikari, Christel Vangestel, Pieter Van Der Veken, Sigrid Stroobants, Filipe Elvas, Koen Augustyns
Pages: 38252 - 38262 - MRI Apparent Diffusion Coefficient (ADC) as a biomarker of tumour response(2023)
Authors: Alan Jackson, Ryan Pathak, Nandita M. deSouza, Yan Liu, Bart K.M. Jacobs, Saskia Litiere, Maria Urbanowicz-Nijaki, Catherine Julie, Arturo Chiti, Jens Theysohn, et al.
Pages: 1 - 15 - The clinical value of combined FDG-PET/CT imaging in response evaluation after chemoradiotherapy in patients with potentially operable locally advanced head and neck squamous cell carcinoma(2023)
Authors: Nils Helsen, Sigrid Stroobants, Tim Van den Wyngaert, Laurens Carp
Number of pages: 148 - ¹⁸F-FDG and ¹⁸F-FLT uptake profiles for breast cancer cell lines treated with targeted PI3K/Akt/mTOR therapies(2023)
Authors: Yanina Dockx, Christel Vangestel, Sven De Bruycker, Tim Van den Wyngaert, Manon Huizing, Steven Staelens, Sigrid Stroobants
Pages: 51 - 61 - Quantification of metabotropic glutamate receptor 5 availability with both [¹¹C]ABP688 and [¹⁸F]FPEB positron emission tomography in the Sapap3 knockout mouse model for obsessive-compulsive–like behavior(2022)
Authors: Dorien Glorie, Jeroen Verhaeghe, Alan Miranda Menchaca, Sigrid Stroobants, Steven Staelens
Pages: 607 - 615 - Synaptic vesicle glycoprotein 2A is affected in the CNS of Huntington’s Disease mice and post-mortem human HD brain(2022)
Authors: Daniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, Alan Miranda Menchaca, Sigrid Stroobants, Ladislav Mrzljak, Celia Dominguez, Mette Skinbjerg, Jonathan Bard, Longbin Liu, et al.
Pages: 942 - 947
Patents
1 - 3 of 3